In late January 2026, Takeda Pharmaceutical reported nine-month FY2025 results showing sales of ¥3,411.18 billions and net income of ¥216.08 billions, alongside slightly higher earnings per share year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results